Page last updated: 2024-08-17

carbostyril and Carcinoma, Small Cell Lung

carbostyril has been researched along with Carcinoma, Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboubakar Nana, F; Detry, B; Dupasquier, S; Feron, O; Ladjemi, MZ; Lecocq, M; Massion, PP; Ocak, S; Pilette, C; Sibille, Y1
Inoue, H; Kato, T; Matsuo, Y; Miyamoto, T; Nakamura, Y; Park, JH; Salgia, R; Zewde, M1

Other Studies

2 other study(ies) available for carbostyril and Carcinoma, Small Cell Lung

ArticleYear
Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
    Molecular cancer therapeutics, 2019, Volume: 18, Issue:1

    Topics: Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinolones; RNA, Small Interfering; Small Cell Lung Carcinoma; Sulfones

2019
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
    Cancer science, 2017, Volume: 108, Issue:3

    Topics: Cell Proliferation; Forkhead Box Protein M1; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplastic Stem Cells; Quinolones; RNA Interference; RNA, Small Interfering; Small Cell Lung Carcinoma; Spheroids, Cellular; Thiophenes; Thy-1 Antigens; Tumor Cells, Cultured

2017